NCT03281447

Brief Summary

In western countries, the number of cancer survivors increases, and current cancer care seems insufficient with both patients' experiences of lack of help in transitions and up to 60 % of the patients having psychological problems after treatment. Further, Denmark shall have new hospitals, where researchers and healthcare professionals are expected to merge tasks and reach a higher patient experienced quality of care, without additional costs, so a better way to provide cancer care, which benefits the patients and supports the ideas within the new hospitals in Denmark, is needed. In a randomized controlled trial, the organizational structure of the healthcare system is challenged and the impact of a coherent nurse navigation practice compared to the currently existing department-specific care coordination is tested. The primary data are changes in patients' self-reported cancer-related self-efficacy from inclusion till one week after receipt of the information that they have reached the end of treatment, or in case of prolonged treatment, till not later than one year after inclusion. Patients can participate if they are 18 years of age or older, speak and understand Danish, and have a proven lesion suspected of cancer in the colon or rectum after colonoscopy or sigmoidoscopy at the Danish endoscopy centers at Odense University Hospital (the cities: Nyborg, Svendborg and Odense) or at Slagelse Hospital. Furthermore, participants must not be mentally retarded, they must not suffer from a constant life-threatening disease, and they must not suffer from, or be in the diagnostic phase of, dementia or severe psychiatric disease. Participants are allocated to support from nurse navigation or to current care coordination, and fill in four questionnaires during their cancer trajectory: 1) At inclusion, 2) Three days before treatment start, 3) One week after receipt of information about treatment end or not later than one year after inclusion, and 4) Six weeks after measure point 3. Data is analyzed using suitable statistical models. With positive results, participants in nurse navigation are better helped during their cancer trajectory and have a better psychological start on the rest of their lives after cancer treatment. Focus will be on colon and rectum cancer care, but the results will be transferable to similar settings. Furthermore, positive results will support changes in the onset of rehabilitation initiatives.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
280

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 26, 2016

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 13, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2017

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

1.7 years

First QC Date

September 11, 2017

Last Update Submit

April 2, 2019

Conditions

Keywords

Nurse navigationFamilySelf EfficacyNeeds assessmentQuality of LifeColorectal NeoplasmsCase Management

Outcome Measures

Primary Outcomes (1)

  • Self evaluated Self Efficacy for Cancer

    Cancer Behaviour Inventory - Brief

    Change in "Cancer Behaviour Inventory - Brief" from inclusion to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.

Secondary Outcomes (15)

  • Self evaluated Self Efficacy for Cancer

    Change in "Cancer Behaviour Inventory - Brief" from inclusion to three days before treatment start.

  • Self evaluated Self Efficacy for Cancer

    Change in "Cancer Behaviour Inventory - Brief" from inclusion to six weeks after measurement 3.

  • Self evaluated Self Efficacy for Cancer

    Change in "Cancer Behaviour Inventory - Brief" from three days before treatment start to measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion.

  • Self evaluated Self Efficacy for Cancer

    Change in "Cancer Behaviour Inventory - Brief" from three days before treatment start to six weeks after measurement 3.

  • Self evaluated Self Efficacy for Cancer

    Change in "Cancer Behaviour Inventory - Brief" from one week after measurement 3: one week after receipt of information about treatment end or not later than one year after inclusion to six weeks after measure point 3.

  • +10 more secondary outcomes

Study Arms (2)

Nurse navigation

EXPERIMENTAL

Coherent navigation and support from a family-centred viewpoint throughout the cancer trajectory, despite the individual patient's affiliation to any department.

Other: Nurse navigation

Current care coordination

ACTIVE COMPARATOR

Department-specific coordination and answers to questions from a patient-centred viewpoint.

Other: Current care coordination

Interventions

Nurse navigation
Current care coordination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Lesions suspected for cancer in the colon or rectum recognized through colonoscopy or sigmoidoscopy found at scopy centres in Odense, Nyborg, Svendborg or Slagelse, all in Denmark
  • Can speak and understand Danish.

You may not qualify if:

  • Life-threatening disease: score 4 in the American Society of Anaesthesiologists status classification system.
  • Dementia ( Diagnosed or in a diagnostic phase).
  • Severe psychiatric disease ( Diagnosed or in a diagnostic phase).
  • Mentally retarded ( Diagnosed or in a diagnostic phase).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Lise Fillion, PhD

    Nursing Faculty, Laval University

    STUDY CHAIR
  • Jens Søndergaard, PhD

    Research Unit of General Practice, Faculty of Health Sciences, University of Southern Denmark

    STUDY CHAIR
  • Marianne K Thygesen, PhD

    Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark and OPEN at Region of Southern Denmark

    PRINCIPAL INVESTIGATOR
  • Niels Qvist, DMSc

    Surgery department A, Clinical Institute, Faculty of Health Sciences, University of Southern Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 11, 2017

First Posted

September 13, 2017

Study Start

February 26, 2016

Primary Completion

October 23, 2017

Study Completion

December 31, 2018

Last Updated

April 4, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share